QUALITY POLICY
Chiman S.r.l. is a contract laboratory founded in 1991, specializing in chemical and chemical-physical analyses for the pharmaceutical area. It performs analytical activities on products and/or samples owned by clients according to protocols established/approved by them and carries out analyses relevant for GMP purposes or for research and development studies.
Chiman is focused on improving global health, with over 25 years of experience in pharmaceutical development and testing. This is achieved by providing a portfolio of analytical and bioanalytical services that help clients transform scientific discoveries into new drugs.
Chiman has a strong commitment to quality in all aspects of the service it offers, aiming to continuously improve the service itself, customer satisfaction and the achievement and maintenance of high quality standards in the various areas of interest.
Our mission is to provide high-quality, customized services to pharmaceutical companies.
Our key resource is flexibility: not only do we work to make the customer’s vision our vision, but we aspire to become partners in their projects.
We focus on analytical chemistry, biochemistry, and medical devices, with experience in both raw materials and conventional finished products, as well as significant experience in the respiratory therapeutic area, combining analytical leadership, innovative technology and scientific expertise in the field to provide cutting-edge service to both customers and patients.
We guarantee the application of good professional practices and ensure the quality of all tests performed, including calibrations, validations, and verifications.
We perform a wide range of services, including:
- analysis of inhalation preparations
- analysis of conventional formulations
- analysis of generic drugs
- analysis of active pharmaceutical ingredients (APIs)
- development studies
- biological analyses
- stability and storage testing
- identification of impurities/degradation products
- analysis for batch release for the market
- analysis for batch release for clinical studies
Chiman S.r.l. has been authorized by AIFA to perform chemical-physical tests on medicines for human use since July 2006 and on experimental medicines since December 2008.
Chiman is authorized by AIFA to perform chemical (F1) and chemical-physical (F2) tests on medicinal products for human use and medicinal products for clinical trials (authorization No. aM – 68/2018 of 05/22/2018) pursuant to Legislative Decree No. 219 of April 24, 2006, No. 219 and subsequent amendments.
Chiman is FDA registered (FEI Number: 3015176596).
“Chiman aims to make a concrete contribution to people’s health and quality of life and to reducing its environmental impact. Chiman’s goal is therefore also to contrast climate change and achieve high levels of sustainability for the planet and for all stakeholders.”
